Recruiting × OTHER × Central Nervous System Neoplasms × Clear all ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Phase 1 Recruiting
18 enrolled
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 Recruiting
24 enrolled
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Phase 1 Recruiting
90 enrolled
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Phase 1/2 Recruiting
65 enrolled
ReRT
Phase NA Recruiting
1,800 enrolled
Characterizing Sleep Among Long-term Survivors of Childhood Cancer
Recruiting
120 enrolled
ASAP
Recruiting
25,000 enrolled
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
Phase 2 Recruiting
52 enrolled
PNOC023
Phase 1 Recruiting
208 enrolled
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Recruiting
200 enrolled
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Phase 2 Recruiting
24 enrolled
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
Phase 2 Recruiting
150 enrolled
A Study of Avutometinib for People With Solid Tumor Cancers
Phase 1 Recruiting
23 enrolled
NEMO
Recruiting
600 enrolled
Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
Recruiting
100 enrolled
A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery
Phase NA Recruiting
500 enrolled
FUS Etoposide for DMG
Phase 1 Recruiting
10 enrolled
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Phase 1/2 Recruiting
90 enrolled
iCaRe2
Recruiting
999,999 enrolled
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
Phase 1 Recruiting
48 enrolled
FCBTR
Recruiting
4,000 enrolled
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Recruiting
5,000 enrolled
Tissue Collection for Drug Screening and Bioanalysis
Recruiting
500 enrolled
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Recruiting
250 enrolled
TARLATEM
Phase 1/2 Recruiting
70 enrolled
DOMINO-START
Phase 4 Recruiting
200 enrolled
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Recruiting
2,500 enrolled
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Phase 1/2 Recruiting
10 enrolled
Brain Slice Explants to Predict Drug Response in Brain Tumors
Recruiting
50 enrolled
CNS Qualitative Interview
Recruiting
20 enrolled
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Recruiting
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
Recruiting
100 enrolled
TRACE
Recruiting
10,000 enrolled
AI-RAD
Recruiting
6,000 enrolled
Cerebrospinal Fluid Biomarkers for Brain Tumors
Recruiting
300 enrolled
Wearable Devices and Biomarkers Project (Healthiomics)
Recruiting
3,500 enrolled
Standard Follow-up Program Neuro-oncology Patients (SFP Neuro-Oncology)
Recruiting
10,000 enrolled
Whole Body Metabolism in Children Before and After Treatment of CNS Tumor
Phase NA Recruiting
30 enrolled
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
Phase 1/2 Recruiting
91 enrolled
GRIPP
Recruiting
400 enrolled